InspireMD (NSPR) Net Income towards Common Stockholders (2010 - 2025)

InspireMD has reported Net Income towards Common Stockholders for 16 years, with the latest figure at $27.3 million in Q4 2025.

• For the quarter ending Q4 2025, Net Income towards Common Stockholders rose 56.64% year-over-year to $27.3 million; the trailing twelve-month figure through Dec 2025 stood at -$10.2 million (down 52.51% YoY), and the FY2025 full-year result was -$48.8 million, down 52.43% from the prior year.
• Net Income towards Common Stockholders for Q4 2025 stood at $27.3 million, up from -$13.1 million in the prior quarter.
• The five-year high for Net Income towards Common Stockholders was $27.3 million in Q4 2025, with the low at -$13.1 million in Q3 2025.
• Historically, Net Income towards Common Stockholders has averaged -$3.6 million across 5 years, with a median of -$4.7 million in 2022.
• Annual changes were most pronounced in 2021 — Net Income towards Common Stockholders sank 85.47% — and 2024, when it surged 400.05%.
• InspireMD's Net Income towards Common Stockholders stood at -$4.1 million in 2021, then declined by 18.88% to -$4.8 million in 2022, then retreated by 20.57% to -$5.8 million in 2023, then surged by 400.05% to $17.4 million in 2024, then surged by 56.64% to $27.3 million in 2025.
• The last three Net Income towards Common Stockholders figures came in at $27.3 million (Q4 2025), -$13.1 million (Q3 2025), and -$13.0 million (Q2 2025), per Business Quant data.